{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:02:01Z","timestamp":1789956121297,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-026-03409-z","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:36:29Z","timestamp":1782473789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring shared decision-making in prostate cancer screening within primary health care settings in Portugal: a cross-sectional study"],"prefix":"10.1186","volume":"27","author":[{"given":"Beatriz","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"de Oliveira Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afonso","family":"Granja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avelino","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico","family":"Teves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"12","key":"3409_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749\u201368. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2996 . PubMed PMID: 31560378.","journal-title":"JAMA Oncol"},{"issue":"3","key":"3409_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/CEJ.0000000000000539","volume":"29","author":"R Braga","year":"2020","unstructured":"Braga R, Costa AR, Pina F, Moura-Ferreira P, Lunet N. Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects. Eur J Cancer Prev. 2020;29(3):248\u201351. 10. 1097\/CEJ.0000000000000539 PubMed PMID: 31651568.","journal-title":"Eur J Cancer Prev"},{"key":"3409_CR3","doi-asserted-by":"publisher","unstructured":"Pina F, Ferro A, Castro C, Bento MJ, Lunet N. Evolu\u00e7\u00e3o da Incid\u00eancia e Mortalidade por Cancro da Pr\u00f3stata em Portugal. Acta Urol\u00f3gica Portuguesa. 2025 Apr;30. https:\/\/doi.org\/10.24915\/aup.224.","DOI":"10.24915\/aup.224"},{"key":"3409_CR4","doi-asserted-by":"publisher","unstructured":"Etzioni R, Gulati R, Cooperberg M, Penson D, Weiss N, Thompson I. Limitations of basing screening policies on screening trials: The US preventive services task force and prostate cancer screening. Med Care. 2013;295\u2013300. https:\/\/doi.org\/10.1097\/MLR.0b013e31827da979 . PubMed PMID: 23269114.","DOI":"10.1097\/MLR.0b013e31827da979"},{"key":"3409_CR5","doi-asserted-by":"publisher","unstructured":"Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2013. https:\/\/doi.org\/10.1002\/14651858.CD004720.pub3 . PubMed PMID: 23440794.","DOI":"10.1002\/14651858.CD004720.pub3"},{"key":"3409_CR6","unstructured":"Cornford P, Tilki D, van den Bergh RCN, Eberli D, De Meerleer G, De Santis M et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. EAU Guidelines Edn presented at the EAU Annual Congress Madrid 2025 ISBN 978-94-92671-29-5. 2025."},{"issue":"2","key":"3409_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.juro","volume":"190","author":"HB Carter","year":"2013","unstructured":"Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early detection of prostate cancer: AUA guideline. J Urol. 2013;190(2):419\u201326. https:\/\/doi.org\/10.1016\/j.juro. 2013.04.119 PubMed PMID: 23659877.","journal-title":"J Urol"},{"key":"3409_CR8","unstructured":"Dire\u00e7\u00e3o. Geral da Sa\u00fade (DGS). Prescri\u00e7\u00e3o e Determina\u00e7\u00e3odo Antig\u00e9nio Espec\u00edfico da Pr\u00f3stata - PSA. Norma de Orienta\u00e7\u00e3o Cl\u00ednica 060\/2011. 2017."},{"issue":"6","key":"3409_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/diseases13060167","volume":"13","author":"Z Dushimova","year":"2025","unstructured":"Dushimova Z, Iztleuov Y, Chingayeva G, Shepetov A, Mustapayeva N, Shatkovskaya O, et al. Overdiagnosis and Overtreatment in Prostate Cancer. Diseases. 2025;13(6):167. https:\/\/doi.org\/10.3390\/diseases13060167 . PubMed PMID: 40558578.","journal-title":"Diseases"},{"key":"3409_CR10","unstructured":"Mulhem E, Duncan N. Prostate Cancer Screening [Internet]. Vol. 92. 2015. Available from: www.aafp.org\/afphttp:\/\/\/\/"},{"key":"3409_CR11","doi-asserted-by":"publisher","unstructured":"Stacey D, Lewis KB, Smith M, Carley M, Volk R, Douglas EE, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Reviews. 2024;2024(1). https:\/\/doi.org\/10.1002\/14651858.CD001431.pub6 . PubMed PMID: 38284415.","DOI":"10.1002\/14651858.CD001431.pub6"},{"issue":"5","key":"3409_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.urpr.2015.10.006","volume":"3","author":"DV Makarov","year":"2016","unstructured":"Makarov DV, Chrouser K, Gore JL, Maranchie J, Nielsen ME, Saigal C, et al. AUA White Paper on Implementation of Shared Decision Making into Urological Practice. Urol Pract. 2016;3(5):355\u201363. https:\/\/doi.org\/10.1016\/j.urpr.2015.10.006.","journal-title":"Urol Pract"},{"key":"3409_CR13","doi-asserted-by":"publisher","unstructured":"Ivlev I, Jerabkova S, Mishra M, Cook LA, Eden KB. Prostate Cancer Screening Patient Decision Aids: A Systematic Review and Meta-analysis. American Journal of Preventive Medicine. Elsevier Inc.; 2018. pp. 896\u2013907. https:\/\/doi.org\/10.1016\/j.amepre.2018.06.016 . PubMed PMID: 30337235.","DOI":"10.1016\/j.amepre.2018.06.016"},{"key":"3409_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4414\/smw.148.14584","volume":"128","author":"NA Martinez-Gonzalez","year":"2018","unstructured":"Martinez-Gonzalez NA, Plate A, Senn O, Markun S, Rosemann T, Neuner-Jehle S. Shared decision-making for prostate cancer screening and treatment: A systematic review of randomised controlled trials. Swiss Med Wkly. 2018;128:7\u20138. https:\/\/doi.org\/10.4414\/smw.148.14584 . PubMed PMID: 29473938.","journal-title":"Swiss Med Wkly"},{"key":"3409_CR15","doi-asserted-by":"publisher","unstructured":"McAlpine K, Lewis KB, Trevena LJ, Stacey D. What Is the Effectiveness of Patient Decision Aids for Cancer-Related Decisions? a systematic review subanalysis. JCO Clin Cancer Inform. 2018;2:1\u201313. https:\/\/doi.org\/10.1200\/CCI.17.00148.","DOI":"10.1200\/CCI.17.00148"},{"issue":"8","key":"3409_CR16","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1001\/jamainternmed.2019.0763","volume":"179","author":"JM Riikonen","year":"2019","unstructured":"Riikonen JM, Guyatt GH, Kilpel\u00e4inen TP, Craigie S, Agarwal A, Agoritsas T, et al. Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis. JAMA Intern Med. 2019;179(8):1072\u201382. https:\/\/doi.org\/10.1001\/jamainternmed.2019.0763 . PubMed PMID: 31233091.","journal-title":"JAMA Intern Med"},{"key":"3409_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1283654","author":"M Estevan-Ortega","year":"2024","unstructured":"Estevan-Ortega M, de la Encarnaci\u00f3n Castellano C, Mendiola-L\u00f3pez A, Parker LA, Caballero-Romeu JP, Lumbreras B. Urologists\u2019 and general practitioners\u2019 knowledge, beliefs and practice relevant for opportunistic prostate cancer screening: a PRISMA-compliant systematic review. Front Med Front Media SA. 2024. https:\/\/doi.org\/10.3389\/fmed.2024.1283654.","journal-title":"Front Med Front Media SA"},{"issue":"754","key":"3409_CR18","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.3399\/BJGP.2024.0376","volume":"75","author":"SWD Merriel","year":"2025","unstructured":"Merriel SWD, Akter N, Zakkak N, Swann R, McPhail S, Rubin G, et al. Factors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis Audit. Br J Gen Pract. 2025;75(754):e300\u20135. 10.3399. \/BJGP.2024.0376 PubMed PMID: 39401928.","journal-title":"Br J Gen Pract"},{"issue":"6","key":"3409_CR19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5489\/cuaj.6680","volume":"15","author":"J Spooner","year":"2021","unstructured":"Spooner J, Birk M, Espinosa V, Hoag N. The times they are a-changin\u2019: The evolution of prostate cancer screening practices and beliefs among primart care physicians in Victoria, British Columbia. Can Urol Assoc J. (Jun; 2021;15(6):192\u20136. https:\/\/doi.org\/10.5489\/cuaj.6680.","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"3409_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11606-020-06124-2","volume":"36","author":"A Shah","year":"2021","unstructured":"Shah A, Polascik TJ, George DJ, Anderson J, Hyslop T, Ellis AM, et al. Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network. J Gen Intern Med. 2021;36(1):92\u20139. https:\/\/doi.org\/10.1007\/s11606-020-06124-2 . PubMed PMID: 32875501.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"3409_CR21","doi-asserted-by":"publisher","first-page":"145e","DOI":"10.1016\/j.urolonc.2022.11.015","volume":"41","author":"J Harper","year":"2023","unstructured":"Harper J, Hunt T, Choudry M, Kapron AL, Cooney KA, Martin C, et al. Clinician interest in clinical decision support for PSA-based prostate cancer screening. Urologic Oncology: Seminars Original Investigations. 2023;41(3):145e. 17-145.e23. PubMed PMID: 36610816.","journal-title":"Urologic Oncology: Seminars Original Investigations"},{"issue":"5","key":"3409_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s10903-024-01606-5","volume":"26","author":"ER Stevens","year":"2024","unstructured":"Stevens ER, Thomas J, Martinez-Lopez N, Fagerlin A, Ciprut S, Shedlin M, et al. Limited Evidence of Shared Decision Making for Prostate Cancer Screening in Audio-Recorded Primary Care Visits Among Black Men and their Healthcare Providers. J Immigr Minor Health. 2024;26(5):866\u201377. https:\/\/doi.org\/10.1007\/s10903-024-01606-5 . PubMed PMID: 38822923.","journal-title":"J Immigr Minor Health"},{"key":"3409_CR23","doi-asserted-by":"publisher","unstructured":"Estevan-Vilar M, Parker LA, Caballero-Romeu JP, Ronda E, Hern\u00e1ndez-Aguado I, Lumbreras B. Barriers and facilitators of shared decision-making in prostate cancer screening in primary care: A systematic review. Preventive Medicine Reports. Elsevier Inc.; 2024. https:\/\/doi.org\/10.1016\/j.pmedr.2023.102539.","DOI":"10.1016\/j.pmedr.2023.102539"},{"key":"3409_CR24","doi-asserted-by":"publisher","unstructured":"Pekala KR, Shill DK, Austria M, Langford AT, Loeb S, Carlsson SV. Shared decision-making before prostate cancer screening decisions. Nat Reviews Urol Nat Res. 2024;329\u201338. https:\/\/doi.org\/10.1038\/s41585-023-00840-0 . PubMed PMID: 38168921.","DOI":"10.1038\/s41585-023-00840-0"},{"key":"3409_CR25","doi-asserted-by":"publisher","unstructured":"Baptista S, Heleno B, Pinto M, Guimar\u00e3es B, China D, Ramos JP, et al. Translation and cultural adaptation of a prostate cancer screening decision aid: A qualitative study in Portugal. BMJ Open. 2020;10(3). https:\/\/doi.org\/10.1136\/bmjopen-2019-034384 . PubMed PMID: 32217563.","DOI":"10.1136\/bmjopen-2019-034384"},{"key":"3409_CR26","doi-asserted-by":"publisher","unstructured":"Ranasinghe WKB, Kim SP, Papa NP, Sengupta S, Frydenberg M, Bolton D, et al. Prostate cancer screening in Primary Health Care: the current state of affairs. Springerplus. 2015;4(1). https:\/\/doi.org\/10.1186\/s40064-015-0819-8.","DOI":"10.1186\/s40064-015-0819-8"},{"key":"3409_CR27","doi-asserted-by":"publisher","unstructured":"Valeriya Angelova-Tosheva, M\u00fcller O. Methodological manual on territorial typologies. Eurostat. 2018;(ISBN 978-92-79-94873-2). https:\/\/doi.org\/10.2785\/930137","DOI":"10.2785\/930137"},{"key":"3409_CR28","doi-asserted-by":"publisher","unstructured":"Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: A model for clinical practice. J Gen Intern Med. 2012;1361\u20137. https:\/\/doi.org\/10.1007\/s11606-012-2077-6 . PubMed PMID: 22618581.","DOI":"10.1007\/s11606-012-2077-6"},{"key":"3409_CR29","doi-asserted-by":"publisher","unstructured":"Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: A systematic review and meta-analysis. BMJ (Online). 2018;362. https:\/\/doi.org\/10.1136\/bmj.k3519 . PubMed PMID: 30185521.","DOI":"10.1136\/bmj.k3519"},{"key":"3409_CR30","doi-asserted-by":"publisher","unstructured":"U.S. Preventive Services Task Force. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(18):1901\u201313. https:\/\/doi.org\/10.1001\/jama.2018.3710.","DOI":"10.1001\/jama.2018.3710"},{"issue":"1","key":"3409_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1370\/afm.1445","volume":"11","author":"RJ Volk","year":"2013","unstructured":"Volk RJ, Linder SK, Kallen MA, Galliher JM, Spano MS, Mullen PD, et al. Primary care physicians\u2019 use of an informed decision-making process for prostate cancer screening. Ann Fam Med. 2013;11(1):67\u201374. https:\/\/doi.org\/10.1370\/afm.1445 . PubMed PMID: 23319508.","journal-title":"Ann Fam Med"},{"key":"3409_CR32","doi-asserted-by":"publisher","unstructured":"Linder SK, Hawley ST, Cooper CP, Scholl LE, Jibaja-Weiss M, Volk RJ. Primary care physicians\u2019 reported use of pre-screening discussions for prostate cancer screening: A cross-sectional survey. BMC Fam Pract. 2009;10. https:\/\/doi.org\/10.1186\/1471-2296-10-19 . PubMed PMID: 19296843.","DOI":"10.1186\/1471-2296-10-19"},{"issue":"1","key":"3409_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11606-006-0015-1","volume":"22","author":"S Marcella","year":"2007","unstructured":"Marcella S, Delnevo CD, Coughlin SS. A national survey of medical students\u2019 beliefs and knowledge in screening for prostate cancer. J Gen Intern Med. 2007;22(1):80\u20135. https:\/\/doi.org\/10.1007\/s11606-006-0015-1 . PubMed PMID: 17351844.","journal-title":"J Gen Intern Med"},{"key":"3409_CR34","doi-asserted-by":"publisher","unstructured":"Benedict MOA, Steinberg WJ, Claassen FM, Mofolo N, van Rooyen C. Knowledge, attitude and practice on screening and early diagnosis of prostate cancer of primary health care providers in the Free State. Afr J Prim Health Care Fam Med. 2023;15(1). https:\/\/doi.org\/10.4102\/phcfm.v15i1. 3688 PubMed PMID: 36861921.","DOI":"10.4102\/phcfm.v15i1"},{"issue":"1","key":"3409_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.22454\/FAMMED","volume":"54","author":"N Shungu","year":"2022","unstructured":"Shungu N, Diaz V, Perkins S, Kulshreshtha A. Physician Attitudes and Self-reported Practices Toward Prostate Cancer Screening in Black and White Men. Fam Med. 2022;54(1):30\u20137. https:\/\/doi.org\/10.22454\/FAMMED. .2022.474827 PubMed PMID: 35006597.","journal-title":"Fam Med"},{"issue":"4","key":"3409_CR36","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.4314\/ahs.v20i4.43","volume":"20","author":"HS Amin","year":"2020","unstructured":"Amin HS, Arafa MA, Farhat KH, Rabah DM, Altaweel AA, Alhammad AH. Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer? Afr Health Sci. 2020;20(4):1870\u20134. https:\/\/doi.org\/10.4314\/ahs.v20i4.43 . PubMed PMID: 34394251.","journal-title":"Afr Health Sci"},{"issue":"11","key":"3409_CR37","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.urolonc.2018.07.016","volume":"36","author":"A Aminsharifi","year":"2018","unstructured":"Aminsharifi A, Schulman A, Anderson J, Fish L, Oeffinger K, Shah K, et al. Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record. Urologic Oncology: Seminars Original Investigations. 2018;36(11):502. https:\/\/doi.org\/10.1016\/j.urolonc.2018.07.016 . PubMed PMID: 30170982.","journal-title":"Urologic Oncology: Seminars Original Investigations"},{"issue":"5","key":"3409_CR38","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s13187-017-1205-8","volume":"33","author":"SK Choi","year":"2018","unstructured":"Choi SK, Seel JS, Steck SE, Payne J, McCormick D, Schrock CS, et al. Talking About Your Prostate: Perspectives from Providers and Community Members. J Cancer Educ. 2018;33(5):1052\u201360. https:\/\/doi.org\/10.1007\/s13187-017-1205-8 . PubMed PMID: 28271389.","journal-title":"J Cancer Educ"},{"issue":"7","key":"3409_CR39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10552-019-01179-x","volume":"30","author":"OL Owens","year":"2019","unstructured":"Owens OL, Kim S, Tavakoli AS. Are decision aids leading to shared prostate cancer screening decisions among African-American men? iDecide. Cancer Causes Control. 2019;30(7):713\u20139. https:\/\/doi.org\/10.1007\/s10552-019-01179-x . PubMed PMID: 31093861.","journal-title":"Cancer Causes Control"},{"key":"3409_CR40","doi-asserted-by":"publisher","unstructured":"Eiriksdottir VK, Baldursdottir B, Fridriksson JO, Valdimarsdottir HB. How much information do icelandic men receive on pros and cons of prostate-specific antigen testing prior to undergoing testing. Am J Mens Health. 2022;16(3):15579883221097805. https:\/\/doi.org\/10.1177\/15579883221097805.\u00a0PubMed PMID: 35608380.","DOI":"10.1177\/15579883221097805"},{"issue":"4","key":"3409_CR41","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s13187-018-1353-5","volume":"34","author":"SH Rim","year":"2019","unstructured":"Rim SH, Hall IJ, Massetti GM, Thomas CC, Li J, Richardson LC. Primary Care Providers\u2019 Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening. J Cancer Educ. 2019;34(4):666\u201370. https:\/\/doi.org\/10.1007\/s13187-018-1353-5 . PubMed PMID: 29582364.","journal-title":"J Cancer Educ"},{"issue":"4","key":"3409_CR42","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/1557988318763673","volume":"12","author":"L Woods-Burnham","year":"2018","unstructured":"Woods-Burnham L, Stiel L, Wilson C, Montgomery S, Dur\u00e1n AM, Ruckle HR, et al. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making. Am J Mens Health. 2018;12(4):751\u20139. doi:10.1177\/1557988318763673 PubMed PMID: 29658371.","journal-title":"Am J Mens Health"},{"issue":"4","key":"3409_CR43","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3122\/jabfm.2018.04","volume":"31","author":"J Li","year":"2018","unstructured":"Li J, Ding H, Richards TB, Martin I, Kobrin S, Marcus PM. Prostate-specific antigen testing initiation and shared decision-making: Findings from the 2000 and 2015 national health interview surveys. J Am Board Fam Med. 2018;31(4):658\u201362. https:\/\/doi.org\/10.3122\/jabfm.2018.04. .170448 PubMed PMID: 29986994.","journal-title":"J Am Board Fam Med"},{"issue":"2","key":"3409_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1370\/afm.2200","volume":"16","author":"SA Fedewa","year":"2018","unstructured":"Fedewa SA, Gansler T, Smith R, Sauer AG, Wender R, Brawley OW, et al. Recent patterns in shared decision making for prostate-specific antigen testing in the United States. Ann Fam Med. 2018;16(2):139\u201344. https:\/\/doi.org\/10.1370\/afm.2200 . PubMed PMID: 29531105.","journal-title":"Ann Fam Med"},{"key":"3409_CR45","doi-asserted-by":"publisher","unstructured":"Misra-Hebert AD, Hom G, Klein EA, Bauman JM, Gupta N, Ji X, et al. Testing of a tool for prostate cancer screening discussions in primary care. Front Oncol. 2018;8(JUN). https:\/\/doi.org\/10.3389\/fonc.2018.00238.","DOI":"10.3389\/fonc.2018.00238"},{"issue":"4","key":"3409_CR46","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1370\/afm.1539","volume":"11","author":"PKJ Han","year":"2013","unstructured":"Han PKJ, Kobrin S, Breen N, Joseph DA, Li J, Frosch DL, et al. National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med. 2013;11(4):306\u201314. https:\/\/doi.org\/10.1370\/afm.1539 . PubMed PMID: 23835816.","journal-title":"Ann Fam Med"},{"key":"3409_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3384\/hygiea.1403-8668.1612169","volume":"12","author":"M Ros\u00e1rio","year":"2016","unstructured":"Ros\u00e1rio M, Martins O, Rodrigues I, Rodrigues T. Regional Trends in Ageing and Health for Portugal. Regional Trends in Ageing and Health for Portugal, 2011\u20132031. Hygiea Internationalis. 2016;12:69\u201395. https:\/\/doi.org\/10.3384\/hygiea.1403-8668.1612169.","journal-title":"Hygiea Internationalis"},{"issue":"3","key":"3409_CR48","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/0272989X211028563","volume":"42","author":"K Scherr","year":"2022","unstructured":"Scherr K, Delaney RK, Ubel P, Kahn VC, Hamstra D, Wei JT, et al. Preparing Patients with Early Stage Prostate Cancer to Participate in Clinical Appointments Using a Shared Decision Making Training Video. Med Decis Making. 2022;42(3):364\u201374. https:\/\/doi.org\/10.1177\/0272989X211028563 . PubMed PMID: 34617827.","journal-title":"Med Decis Making"},{"key":"3409_CR49","doi-asserted-by":"publisher","unstructured":"Pathirana TI, Pickles K, Riikonen JM, Tikkinen KAO, Bell KJL, Glasziou P. Including Information on Overdiagnosis in Shared Decision Making: A Review of Prostate Cancer Screening Decision Aids. MDM Policy Pract. 2022;7(2). https:\/\/doi.org\/10.1177\/23814683221129875.","DOI":"10.1177\/23814683221129875"},{"issue":"5","key":"3409_CR50","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.juro.2018.05.093","volume":"200","author":"AB Weiner","year":"2018","unstructured":"Weiner AB, Tsai KP, Keeter MK, Victorson DE, Schaeffer EM, Catalona WJ, et al. The Influence of Decision Aids on Prostate Cancer Screening Preferences: A Randomized Survey Study. J Urol. 2018;200(5):1048\u201355. https:\/\/doi.org\/10.1016\/j.juro.2018.05.093 . PubMed PMID: 29852180.","journal-title":"J Urol"},{"issue":"4","key":"3409_CR51","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.amepre.2015.03.002","volume":"49","author":"MJ Barry","year":"2015","unstructured":"Barry MJ, Wexler RM, Brackett CD, Sepucha KR, Simmons LH, Gerstein BS, et al. Responses to a decision aid on prostate cancer screening in primary care practices. Am J Prev Med. 2015;49(4):520\u20135. 03.002 PubMed PMID: 25960395.","journal-title":"Am J Prev Med"},{"key":"3409_CR52","doi-asserted-by":"publisher","unstructured":"Pickles K, Kazda L, Barratt A, McGeechan K, Hersch J, McCaffery K. Evaluating two decision AIDS for Australian men supporting informed decisions about prostate cancer screening: A randomised controlled trial. PLoS ONE. 2020;15(1). https:\/\/doi.org\/10.1371\/journal.pone.0227304 . PubMed PMID: 31940376.","DOI":"10.1371\/journal.pone.0227304"},{"key":"3409_CR53","doi-asserted-by":"publisher","unstructured":"Tiedje D, Borowski M, Simbrich A, Schl\u00f6\u00dfler K, Kruse K, Bothe C, et al. Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial. Sci Rep. 2021;11(1). https:\/\/doi.org\/10.1038\/s41598-021-02696-z . PubMed PMID: 34873188.","DOI":"10.1038\/s41598-021-02696-z"},{"issue":"2","key":"3409_CR54","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1177\/1460458219873528","volume":"26","author":"JJ van Tol-Geerdink","year":"2020","unstructured":"van Tol-Geerdink JJ, van Oort IM, Somford DM, Wijburg CJ, Geboers A, van Uden-Kraan CF, et al. Implementation of a decision aid for localized prostate cancer in routine care: A successful implementation strategy. Health Inf J. 2020;26(2):1194\u2013207. doi:10.1177\/1460458219873528 PubMed PMID: 31566466.","journal-title":"Health Inf J"},{"key":"3409_CR55","doi-asserted-by":"publisher","unstructured":"Smeenge M, Barentsz J, Cosgrove D, De La Rosette J, De Reijke T, Eggener S, et al. Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: Report from a Consensus Panel. BJU Int. 2012;942\u20138. https:\/\/doi.org\/10.1111\/j.1464-410X. .2012.11072.x PubMed PMID: 22462566.","DOI":"10.1111\/j.1464-410X"},{"issue":"1","key":"3409_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1590\/0100-3984.2013.0010","volume":"48","author":"PM Lopes","year":"2015","unstructured":"Lopes PM, Sep\u00falveda L, Ramos R, Sousa P. O papel da ecografia transretal no diagn\u00f3stico do c\u00e2ncer da pr\u00f3stata: Novas contribui\u00e7\u00f5es. Radiol Bras. 2015;48(1):7\u201311. https:\/\/doi.org\/10.1590\/0100-3984.2013.0010.","journal-title":"Radiol Bras"},{"key":"3409_CR57","doi-asserted-by":"publisher","unstructured":"Harvey CJ, Pilcher J, Richenberg J, Patel U, Frauscher F. Applications of transrectal ultrasound in prostate cancer. British Journal of Radiology. 2012;85(SPEC. ISSUE 1). https:\/\/doi.org\/10.1259\/bjr\/56357549 PubMed PMID: 22844031.","DOI":"10.1259\/bjr\/56357549"},{"issue":"3","key":"3409_CR58","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3348\/kjr.2009.10.3.244","volume":"10","author":"YL Ho","year":"2009","unstructured":"Ho YL, Hak JL, Byun SS, Sang EL, Sung KH, Seung HK. Classification of focal prostatic lesions on transrectal ultrasound (TRUS) and the accuracy of TRUS to diagnose prostate cancer. Korean J Radiol. 2009;10(3):244\u201351. https:\/\/doi.org\/10.3348\/kjr.2009.10.3.244 . PubMed PMID: 19412512.","journal-title":"Korean J Radiol"},{"issue":"1","key":"3409_CR59","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","volume":"20","author":"O Rouvi\u00e8re","year":"2019","unstructured":"Rouvi\u00e8re O, Puech P, Renard-Penna R, Claudon M, Roy C, M\u00e8ge-Lechevallier F, et al. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2019;20(1):100\u20139. 2045(18)30569-2 PubMed PMID: 30470502.","journal-title":"Lancet Oncol"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-026-03409-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-026-03409-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-026-03409-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:35:27Z","timestamp":1789954527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12875-026-03409-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3409"],"URL":"https:\/\/doi.org\/10.1186\/s12875-026-03409-z","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of ULS Santo Ant\u00f3nio | ICBAS, and by the Office of Research Projects of the Clinical Academic Centre with the reference number 2024.102 (089-DEFI\/091 CE) and conducted in accordance with the Declaration of Helsinki. Informed consent was obtained through an implied consent process; participants received an information page and by completing the questionnaire, they consented to participate. Participation was voluntary and completely anonymous.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"333"}}